<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2959862-A1" country="EP" doc-number="2959862" kind="A1" date="20151230" family-id="53773187" file-reference-id="303792" date-produced="20180825" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="160452816" ucid="EP-2959862-A1"><document-id><country>EP</country><doc-number>2959862</doc-number><kind>A1</kind><date>20151230</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-15173417-A" is-representative="YES"><document-id mxw-id="PAPP193868600" load-source="docdb" format="epo"><country>EP</country><doc-number>15173417</doc-number><kind>A</kind><date>20150623</date><lang>EN</lang></document-id><document-id mxw-id="PAPP193868601" load-source="patent-office" format="original"><country>EP</country><doc-number>15173417.5</doc-number><date>20150623</date><lang>EN</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC162034929" ucid="US-201414313685-A" load-source="docdb"><document-id format="epo"><country>US</country><doc-number>201414313685</doc-number><kind>A</kind><date>20140624</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL-1988519740" load-source="docdb">A61F   2/00        20060101ALI20151020BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1988521965" load-source="docdb">A61C   8/02        20060101AFI20151020BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1988524430" load-source="docdb">A61F   2/28        20060101ALI20151020BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-1777709834" load-source="docdb" scheme="CPC">A61F2002/30971     20130101 LA20170731BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1777709835" load-source="docdb" scheme="CPC">A61F2002/30029     20130101 LA20170731BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1777709836" load-source="docdb" scheme="CPC">A61F2002/30062     20130101 LA20170731BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1796761037" load-source="docdb" scheme="CPC">A61F2002/0068      20130101 LA20170626BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1984696771" load-source="docdb" scheme="CPC">A61C   8/0006      20130101 LI20160106BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1984696884" load-source="docdb" scheme="CPC">A61F2002/2835      20130101 LA20151224BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1984697036" load-source="docdb" scheme="CPC">A61L  27/56        20130101 LI20151224BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1984699475" load-source="docdb" scheme="CPC">A61L  27/18        20130101 LI20151224BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1984700890" load-source="docdb" scheme="CPC">A61L2430/02        20130101 LA20151224BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1984701445" load-source="docdb" scheme="CPC">A61F2210/0076      20130101 LA20151224BHEP        </classification-cpc><classification-cpc mxw-id="PCL-1984705139" load-source="docdb" scheme="CPC">A61F   2/2846      20130101 FI20160106BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT165549914" lang="DE" load-source="patent-office">PERFORIERTE MEMBRAN ZUR GEFÜHRTEN KNOCHEN- UND GEWEBEREGENERATION</invention-title><invention-title mxw-id="PT165549915" lang="EN" load-source="patent-office">PERFORATED MEMBRANE FOR GUIDED BONE AND TISSUE REGENERATION</invention-title><invention-title mxw-id="PT165549916" lang="FR" load-source="patent-office">MEMBRANE PERFORÉE POUR LA RÉGÉNÉRATION OSSEUSE ET TISSULAIRE GUIDÉE</invention-title><citations><patent-citations><patcit mxw-id="PCIT335744287" load-source="docdb" ucid="DE-102012024206-A1"><document-id format="epo"><country>DE</country><doc-number>102012024206</doc-number><kind>A1</kind><date>20140618</date></document-id><sources><source name="SEA" category="X" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT335741957" load-source="docdb" ucid="US-20080044449-A1"><document-id format="epo"><country>US</country><doc-number>20080044449</doc-number><kind>A1</kind><date>20080221</date></document-id><sources><source name="SEA" category="Y" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT335745596" load-source="docdb" ucid="US-20100217392-A1"><document-id format="epo"><country>US</country><doc-number>20100217392</doc-number><kind>A1</kind><date>20100826</date></document-id><sources><source name="SEA" category="X" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT335742774" load-source="docdb" ucid="US-6409764-B1"><document-id format="epo"><country>US</country><doc-number>6409764</doc-number><kind>B1</kind><date>20020625</date></document-id><sources><source name="SEA" category="Y" created-by-npl="N"/></sources></patcit><patcit mxw-id="PCIT335746353" load-source="docdb" ucid="US-8556990-B2"><document-id format="epo"><country>US</country><doc-number>8556990</doc-number><kind>B2</kind><date>20131015</date></document-id><sources><source name="APP" created-by-npl="N"/></sources></patcit></patent-citations></citations></technical-data><parties><applicants><applicant mxw-id="PPAR1103315496" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>OSTEOGENICS BIOMEDICAL INC</last-name><address><country>US</country></address></addressbook></applicant><applicant mxw-id="PPAR1103324128" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>OSTEOGENICS BIOMEDICAL INC.</last-name></addressbook></applicant><applicant mxw-id="PPAR1101640015" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Osteogenics Biomedical Inc.</last-name><iid>101532037</iid><address><street>4620 71st Street Building 78</street><city>Lubbock, TX 79424</city><country>US</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR1103309529" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>BARTEE BARRY K</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR1103332102" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>BARTEE, BARRY K.</last-name></addressbook></inventor><inventor mxw-id="PPAR1101640306" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>BARTEE, BARRY K.</last-name><address><street>4016 104th Street</street><city>Lubbock, TX Texas 79423</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR1103314880" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>BARTEE CHAD M</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR1103319967" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>BARTEE, CHAD M.</last-name></addressbook></inventor><inventor mxw-id="PPAR1101650676" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>BARTEE, CHAD M.</last-name><address><street>Osteogenics Biomedical Inc. 4006 110th Street</street><city>Lubbock, TX Texas 79423</city><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR1103318885" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>URBAN ISTVÁN</last-name><address><country>US</country></address></addressbook></inventor><inventor mxw-id="PPAR1103309902" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>URBAN, István</last-name></addressbook></inventor><inventor mxw-id="PPAR1101640491" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>URBAN, István</last-name><address><street>10663 Cranks Rd.</street><city>Culver City, CA California 90230</city><country>US</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR1101653215" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Lantos, Mihaly</last-name><iid>100053178</iid><address><street>Danubia Patent &amp; Law Office LLC Bajcsy-Zsilinszky út 16</street><city>1051 Budapest</city><country>HU</country></address></addressbook></agent></agents></parties><international-convention-data><designated-states><ep-contracting-states><country mxw-id="DS660707206" load-source="docdb">AL</country><country mxw-id="DS660790156" load-source="docdb">AT</country><country mxw-id="DS660629280" load-source="docdb">BE</country><country mxw-id="DS660714072" load-source="docdb">BG</country><country mxw-id="DS660708011" load-source="docdb">CH</country><country mxw-id="DS660629281" load-source="docdb">CY</country><country mxw-id="DS660790157" load-source="docdb">CZ</country><country mxw-id="DS660707212" load-source="docdb">DE</country><country mxw-id="DS660629282" load-source="docdb">DK</country><country mxw-id="DS660629291" load-source="docdb">EE</country><country mxw-id="DS660731530" load-source="docdb">ES</country><country mxw-id="DS660714073" load-source="docdb">FI</country><country mxw-id="DS660708012" load-source="docdb">FR</country><country mxw-id="DS660707213" load-source="docdb">GB</country><country mxw-id="DS660629292" load-source="docdb">GR</country><country mxw-id="DS660707214" load-source="docdb">HR</country><country mxw-id="DS660790158" load-source="docdb">HU</country><country mxw-id="DS660708013" load-source="docdb">IE</country><country mxw-id="DS660629293" load-source="docdb">IS</country><country mxw-id="DS660714074" load-source="docdb">IT</country><country mxw-id="DS660629294" load-source="docdb">LI</country><country mxw-id="DS660714091" load-source="docdb">LT</country><country mxw-id="DS660629578" load-source="docdb">LU</country><country mxw-id="DS660714092" load-source="docdb">LV</country><country mxw-id="DS660714093" load-source="docdb">MC</country><country mxw-id="DS660629583" load-source="docdb">MK</country><country mxw-id="DS660629584" load-source="docdb">MT</country><country mxw-id="DS660629311" load-source="docdb">NL</country><country mxw-id="DS660707220" load-source="docdb">NO</country><country mxw-id="DS660629312" load-source="docdb">PL</country><country mxw-id="DS660714094" load-source="docdb">PT</country><country mxw-id="DS660790159" load-source="docdb">RO</country><country mxw-id="DS660714099" load-source="docdb">RS</country><country mxw-id="DS660629313" load-source="docdb">SE</country><country mxw-id="DS660708014" load-source="docdb">SI</country><country mxw-id="DS660707221" load-source="docdb">SK</country><country mxw-id="DS660707222" load-source="docdb">SM</country><country mxw-id="DS660629585" load-source="docdb">TR</country></ep-contracting-states><ep-extended-states><ep-extended-state-data><country>BA</country></ep-extended-state-data><ep-extended-state-data><country>ME</country></ep-extended-state-data></ep-extended-states></designated-states></international-convention-data></bibliographic-data><abstract mxw-id="PA166480914" lang="EN" load-source="patent-office"><p id="pa01" num="0001">This disclosure describes a membrane configured to guide bone and tissue regeneration for a bone defect (1402). The membrane comprises a first layer, a second layer, one or more perforations (18), a flexible reinforcement or binder (12), and/or other components. The first layer of the membrane is configured to contact bone (1400). The first layer includes pores configured to promote ingrowth of bone regenerating cells into the first layer. The second layer is configured to substantially prevent fibrous connective tissue from growing into the bone defect. The second layer comprises a relatively dense structure and is fixedly coupled to the first layer. The perforations (18) may comprise co-axial through-holes having common dimensions through the first layer and the second layer. The perforations enhance ossification.
<img id="iaf01" file="imgaf001.tif" wi="78" he="118" img-content="drawing" img-format="tif"/></p></abstract><abstract mxw-id="PA166760726" lang="EN" source="EPO" load-source="docdb"><p>This disclosure describes a membrane configured to guide bone and tissue regeneration for a bone defect (1402). The membrane comprises a first layer, a second layer, one or more perforations (18), a flexible reinforcement or binder (12), and/or other components. The first layer of the membrane is configured to contact bone (1400). The first layer includes pores configured to promote ingrowth of bone regenerating cells into the first layer. The second layer is configured to substantially prevent fibrous connective tissue from growing into the bone defect. The second layer comprises a relatively dense structure and is fixedly coupled to the first layer. The perforations (18) may comprise co-axial through-holes having common dimensions through the first layer and the second layer. The perforations enhance ossification.</p></abstract><description mxw-id="PDES98405615" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001"><b><i>FIELD</i></b></heading><p id="p0001" num="0001">This disclosure relates to a membrane configured to guide bone and tissue regeneration for a bone defect.</p><heading id="h0002"><b><i>BACKGROUND</i></b></heading><p id="p0002" num="0002">It is widely known that the occurrence of tooth loss in human dentition (which may happen as the result of dental diseases, advanced age, genetic inclination, accidents, etc.) is the cause of a number of functional and aesthetic problems. For example, if chewing is unsatisfactory, the entire digestive system may be affected, and the unsatisfactory chewing may cause gastrointestinal dysfunction and complaints.-From an aesthetic point of view, properly cared for teeth have considerable significance.</p><p id="p0003" num="0003">Previously, missing teeth were replaced with a partial denture or a permanently attached dental bridge, supported in part by the remaining natural teeth. Bridges, however, are multi-piece inflexible systems, the shape and color of which do not always conform to expectations, and their participation in the chewing process is also frequently imperfect. Contemporary tooth replacement includes the extraction of damaged or hopeless teeth and implantation titanium implants supported by the patients own natural bone. If there is inadequate bone for implant support, this bone may be reconstructed using autogenous bone grafts. This, however, is an expensive procedure, which may require hospitalization and in certain cases possible complications. Other options for bone reconstruction include guided tissue regeneration (GTR) and bone regeneration (GBR). Both of these techniques involve the regeneration of bone deficiencies affecting natural teeth by means of barrier membranes. GTR implies the regeneration of the bone and attachment apparatus (ligaments, cementum) of natural teeth, whereas GBR includes the implantation of a membrane into the location where the formation of bone is intended. For either technique, bone and/or bone replacement material is typically used under the membrane. Currently, the membranes used for GTR/GBR do not include macro-perforations in the membrane, but rather are engineered to be cell-occlusive while simultaneously being able to allow the passage of small molecules. It is widely accepted that the membrane functions as a barrier to protect the healing environment form soft tissue ingrowth and resorptive stimuli. The<!-- EPO <DP n="2"> --> present invention describes modifications to traditional GTR/GBR membranes designed to increase the potential for communication between cells with bone forming potential and the periosteum, while simultaneously providing stability and protection of the three-dimensional envelope of space so that bone may form guided by the final contour of the membrane.</p><heading id="h0003"><b><i>SUMMARY</i></b></heading><p id="p0004" num="0004">One aspect of the disclosure relates to a membrane configured to guide bone and tissue regeneration for a bone defect. The membrane may comprise a first layer, a second layer, one or more perforations, a reinforcement binder, and/or other components. The first layer of the membrane may be configured to contact bone. (This is not intended to be limiting. In some situations a user may place the first layer of the membrane in contact with soft and/or other non-bone tissue). The first layer may include pores configured to promote ingrowth of bone regenerating cells into the first layer. The second layer may be configured to substantially prevent fibrous connective tissue from growing into the bone defect. In some implementations, the second layer may be relatively denser than the first layer. The second layer may comprise a densely woven structure, depending on the material used to make the second layer, for example. The second layer may be fixedly coupled to the first layer. In some implementations, the membrane may be formed from collagen, polytetrafluoroethylene (PTFE), bioresorbable polymer, animal tissue, human tissue, a combination thereof, and/or other materials.</p><p id="p0005" num="0005">In some implementations, the first layer may consist of a thin layer of expanded PTFE and/or other lightweight mesh polymer materials having a pore size in the range of about 30 microns to about 1000 microns. The first layer may cover the second layer of dense PTFE (for example). This would create a two-layer membrane, one layer being an open-structured mesh and the second being a high density, cell occlusive material.</p><p id="p0006" num="0006">The one or more perforations may be formed through the membrane. In some implementations, the perforations may be complete through both the first and the second layer. In some implementations, the perforations may comprise co-axial through-holes having common dimensions through the first layer and the second layer. In some implementations (such as when the first layer is a thin layer of expanded PTFE having a pore size in the range of about 30 microns to about 1000 microns as described above), the holes may be complete only though the dense second layer. The perforations may be configured to enhance ossification. In some implementations, the perforations may be substantially circular, and/or have other shapes. In some implementations, the perforations<!-- EPO <DP n="3"> --> may have a diameter of about 0.1mm or larger. In some implementations, the perforations may be substantially circular and may have a diameter of about 0.5mm to about 1.0mm. In some implementations, a size, a density, a spacing, and/or other characteristics of the perforations may be determined based on one or more of a material that forms the membrane, a thickness of the membrane, a size (e.g., a length and/or a width) of the membrane, and/or other factors.</p><p id="p0007" num="0007">In some implementations, the membrane may include one or more secondary perforations configured to receive fasteners configured to hold the membrane in place at the bone defect. In some implementations, the fasteners may be pins and/or other fastening devices.</p><p id="p0008" num="0008">The reinforcement binder may be configured to be placed over the bone defect and coupled with surrounding bone. The reinforcement binder may comprise multiple elongated members extending from a junction. The elongated members may include a first elongated member, for example, having a free end that extends away from the junction with a predrilled hole formed therein. The predrilled hole may be configured to receive a fastener that passes through at least one of the first or second layer of the membrane and holds the membrane in place at the bone defect. In some implementations, the reinforcement binder may be formed between the first layer and the second layer of the membrane. In some implementations, the reinforcement binder may be a titanium reinforcement binder and may be configured to be bent into a desired shape by a user.</p><p id="p0009" num="0009">Another aspect of the disclosure relates to a method for guiding bone and tissue regeneration for a bone defect with a membrane. The method may comprise forming a first layer of the membrane configured to contact bone and/or other tissue. The first layer may be made from lightweight polymer mesh, collagen, expanded PTFE, and/or other materials. The first layer may be formed with or without perforations (e.g., macropores and/or holes). Whether or not the first layer is formed with perforations, the first layer may include pores configured to promote ingrowth of bone regenerating cells and communication between cells and the periosteum into the first layer. The method may include forming a second layer of the membrane configured to substantially prevent fibrous connective tissue from growing into the bone defect. In some implementations, the second layer may be relatively denser than the first layer. The second layer may comprise a densely woven structure, depending on the material used to make the second layer, for example. The method may comprise fixedly coupling the second layer to the first layer. The method may comprise<!-- EPO <DP n="4"> --> forming one or more perforations through the membrane. The perforations may comprise co-axial through-holes having common dimensions through the first layer and the second layer. The perforations may be configured to enhance ossification. In some implementations, the perforations may be formed in the second layer only. In some implementations, the membrane may be formed from collagen, polytetrafluoroethylene (PTFE), bioresorbable polymer, animal tissue, human tissue, a combination thereof, and/or other materials.</p><p id="p0010" num="0010">In some implementations, forming the one or more perforations may include forming the perforations with a substantially circular cross section having a diameter of about 0.1 mm or larger. In some implementations, forming the one or more perforations may include forming the perforations with a substantially circular cross section having a diameter of about 0.5mm to about 1.0mm. In some implementations, the method may comprise determining one or more of a size, a density, a spacing, and/or other characteristics of the perforations based on one or more of a material that forms the membrane, a thickness of the membrane, a size of the membrane, and/or other factors.</p><p id="p0011" num="0011">In some implementations, the method may comprise forming one or more secondary perforations configured to receive fasteners configured to hold the membrane in place at the bone defect. The fasteners may be pins, for example, and/or other fastening devices.</p><p id="p0012" num="0012">In some implementations, the method may comprise forming a reinforcement binder. The reinforcement binder may comprise multiple elongated members extending from a junction. The elongated members may include a first elongated member, for example, having a free end that extends away from the junction with a predrilled hole formed therein. The method may comprise placing the membrane and the reinforcement binder over the bone defect, receiving a fastener with the predrilled hole that passes through at least one of the first or second layer of the membrane, and coupling the membrane and the reinforcement binder with surrounding bone and holding the membrane in place at the bone defect via the fastener. In some implementations the reinforcement binder may be formed between the first layer and the second layer of the membrane. In some implementations, the reinforcement binder may be formed from titanium and may receive a shape imparted to the reinforcement binder via bending by a user.</p><p id="p0013" num="0013">These and other objects, features, and characteristics of the system and/or method disclosed herein, as well as the methods of operation and functions of the related elements of structure and the combination of parts and economies of manufacture, will become more<!-- EPO <DP n="5"> --> apparent upon consideration of the following description and the appended claims with reference to the accompanying drawings, all of which form a part of this specification, wherein like reference numerals designate corresponding parts in the various figures. It is to be expressly understood, however, that the drawings are for the purpose of illustration and description only and are not intended as a definition of the limits of the invention. As used in the specification and in the claims, the singular form of "a", "an", and "the" include plural referents unless the context clearly dictates otherwise.</p><heading id="h0004"><b><i>BRIEF DESCRIPTION OF THE DRAWINGS</i></b></heading><p id="p0014" num="0014"><ul><li><figref idrefs="f0001">FIG. 1</figref> illustrates a membrane configured to guide bone and tissue regeneration for a bone defect.</li><li><figref idrefs="f0002">FIG. 2</figref> illustrates a membrane without a reinforcement binder.</li><li><figref idrefs="f0003">FIG. 3</figref> illustrates first layer of the membrane.</li><li><figref idrefs="f0004">FIG. 4</figref> illustrates a second layer of the membrane.</li><li><figref idrefs="f0005">FIG. 5</figref> illustrates a texture pattern formed in the second layer of the membrane.</li><li><figref idrefs="f0006">FIG. 6</figref> illustrates an example implementation of a reinforcement binder.</li><li><figref idrefs="f0007">FIG. 7</figref> illustrates an example implementation of the reinforcement binder.</li><li><figref idrefs="f0008">FIG. 8</figref> is a lateral cross-sectional view of an adult human maxilla after a tooth extraction showing alveolar bone.</li><li><figref idrefs="f0009">FIG. 9</figref> shows a tooth socket packed with bone and covered with a membrane.</li><li><figref idrefs="f0010">FIG. 10</figref> shows a typical tooth extraction site after healing, but prior to removal of a membrane.</li><li><figref idrefs="f0011">FIG. 11</figref> illustrates a method for guiding bone and tissue regeneration for a bone defect with a membrane.</li><li><figref idrefs="f0012">FIG. 12</figref> illustrates an example of the membrane wherein the second layer includes perforations but the first layer does not.</li><li><figref idrefs="f0013">FIG. 13</figref> illustrates treatment of a discontinuity defect with the membrane.</li><li><figref idrefs="f0014">FIG. 14</figref> illustrates treatment of a vertical defect with the membrane.</li><li><figref idrefs="f0015">FIG. 15</figref> illustrates treatment of a horizontal defect with the membrane.</li></ul></p><heading id="h0005"><b><i>DETAILED DESCRIPTION</i></b></heading><!-- EPO <DP n="6"> --><p id="p0015" num="0015"><figref idrefs="f0001">FIG. 1</figref> illustrates membrane 10. Membrane 10 may be configured to guide bone and tissue regeneration for a bone defect. Membrane 10 may be suitable for guided bone regeneration (GBR), guided tissue regeneration (GTR), and/or other therapies. Membrane 10 may form a barrier membrane used for guiding bone and tissue regeneration for dental and/or other purposes. Membrane 10 may be used in oral surgery, maxillofacial surgery, craniofacial surgery, to treat periodontal diseases, for dental implants, to treat orbital floor bone defects, and/or for other applications. Membrane 10 may be configured to maintain space for bone regeneration, to prevent connective tissue fibers from growing into the bone tissue, to immobilize bone, to exclude stimuli, which may hinder bone generation, and/or for other purposes. Membrane 10 may be a barrier membrane that is applicable in alveolar ridge defect replacements and/or for other defects that membrane 10 is sized to cover. Membrane 10 may facilitate reducing and/or eliminating injuries, and/or facilitate a more efficient bone and tissue regeneration process compared to previously known techniques. Membrane 10 may include perforations 18 located at various distances from each other throughout membrane 10.</p><p id="p0016" num="0016">Perforations 18 in membrane 10 may be based on the surprising discovery that if a barrier membrane does not constitute a continuous surface at the location of the desired bone and tissue regeneration (e.g. if the membrane includes perforations that are larger than a pore size in a surface of the membrane) the membrane still induces a positive effect on bone regeneration, especially when combined with the use of various biological growth factors. Membranes with perforations have been shown to better facilitate bone regeneration than membranes without perforations. The perforated design also makes the membrane easier to handle, fixate, and/or shape during application because the surgeon may more readily visualize, for example, pilot holes made specifically for the purpose of securing membrane fixation screws, pins or tacks.</p><p id="p0017" num="0017">A perforated membrane may facilitate communication between a patient's periosteum and growth factors used with GBR. The growth factors may include RhPDGF (Platelet Derived Growth Factor), RhBMP (Bone Morphogenetic Protein), and/or other growth factors. The perforations may also facilitate communication between the periosteum and undifferentiated stem cells, especially in the presence of simulative growth factors. Application of a non-perforated collagen (for example) membrane may reduce the regenerative potential of PDGF. If a surgeon (and/or other users) utilizes ground autogenous bone for bone generation, which makes the application of a membrane<!-- EPO <DP n="7"> --> necessary, the "permeability" of a perforated membrane may make the development of a connection with the periosteal membrane possible using the PDGF technique.</p><p id="p0018" num="0018">Similarly, membrane 10 may be used with RhBMP. Using membrane 10 with RhBMP may allow a surgeon (and/or other users) to avoid using a titanium net/mesh (used for its permeability relative to a non-perforated membrane), for example. A titanium net/mesh may cause complications because it is sharp and difficult to handle. Such complications may include, for example, damaging the gum of a patient or difficult removal (taking as long as thirty minutes). Conversely, membrane 10 may be removable in a matter of a few minutes, which decreases the duration of surgery and the possible occurrences of complications.</p><p id="p0019" num="0019">Continuing with the above non-limiting example comparison to the titanium net/mesh, the present invention differs from titanium mesh in several respects. These include mechanical compliance, placement, removal, customization, and/or other differences. (1) Mechanical Compliance: perforated PTFE is more flexible, and therefore has improved compliance with soft tissue compared to titanium mesh. Mechanical compliance is important because biomaterials that are compliant with soft tissue have a much less reduced risk of soft tissue dehiscence (opening) and/or wound healing complications. (2) Placement: because of its flexibility and softness, membrane 10 easier to adapt, place, and/or fixate compared to titanium mesh. (3) Removal: regenerated bone tends to grow through and/or over the the titanium mesh struts, making it exceedingly difficult to remove. During removal of titanium mesh, damage to the immature regenerated bone may occur, resulting in less volume of regenerated tissue than desired. In contrast, with membrane 10 being flexible, it is much easier to remove and in fact is able to stretch and therefore presents less risk of damaging the newly formed bone tissue as the device is removed. (4) Customization: relating to method, in a 'custom fit' application, the present invention is much easier to trim and cut, and/or the surgeon may easily punch holes directly at the time of surgery with a simple hand punch, enabling the creation of a truly custom surgical device for individual defects. The surgeon may place the holes in exactly the location desired, and they may make more holes, or fewer holes depending on the clinical indication. For example, it may be advantageous in a case where membrane exposure was desired, to leave the exposed portion non-perforated and to create perforations in the areas where communication between the periosteum and graft bed was desired. This maneuver would be exceedingly difficult to accomplish with a sheet of titanium.<!-- EPO <DP n="8"> --></p><p id="p0020" num="0020">In some implementations, membrane 10 may include a first layer 14 (<figref idrefs="f0003">FIG. 3</figref>), a second layer 16 (<figref idrefs="f0004">FIG. 4</figref>), one or more perforations 18, a reinforcement binder 12, and/or other components. In some implementations, the first layer may be non-perforated, and consist of a thin layer of lightweight polymer mesh, collagen or expanded PTFE. In some implementations, the perforations may only be complete through a single layer of the membrane, with the layer of lightweight polymer mesh, collagen, or expanded PTFE bonded (for example) to it. Said membrane may or may not contain a titanium framework between the layers. In some implementations, membrane 10 may not include reinforcement binder 12. For example, <figref idrefs="f0002">FIG. 2</figref> illustrates membrane 10 without reinforcement binder 12. First layer 14, second layer 16, reinforcement binder 12, and/or other components of membrane 10 may be similar to and/or the same as similar components described in United States Patent Number<patcit id="pcit0001" dnum="US8556990B"><text> 8,556,990 granted on October 15, 2013</text></patcit>, and entitled, "Reinforced PTFE Medical Barriers," which is hereby incorporated herein by reference in its entirety.</p><p id="p0021" num="0021">As shown in <figref idrefs="f0002">FIG. 2</figref>, membrane 10 may be generally rectangular and have a length 42 and a width 22. In some implementations, length 42 may be less than about 50mm. Length 42 may be between about 30mm and about 50mm. Length 42 may be about 40mm. In some implementations, width 22 may be less than about 40mm. Width 22 may be between about 20mm and about 40mm. Width may be about 30mm. In some implementations, membrane 10 may have a thickness from about 0.125 mm to about 0.25 mm. The generally rectangular shape and approximate dimensions of membrane 10 shown in <figref idrefs="f0002">FIG. 2</figref> are not intended to be limiting. Membrane 10 may take any shape and have any dimensions that allow it to function as described in the present disclosure.</p><p id="p0022" num="0022">In some implementations, membrane 10 may be formed from collagen, polytetrafluoroethylene (PTFE), and/or other materials, and/or a combination of materials. In some implementations, membrane 10 made be formed from one or more of expanded PTFE, unsintered PTFE, high density PTFE, and/or other materials. In some implementations, one or more layers 14, 16 (<figref idrefs="f0003">FIG. 3</figref> and <figref idrefs="f0004">FIG. 4</figref>) of membrane 10 (e.g., second layer 16) may be formed from unsintered substantially unexpanded PTFE. The term sintered is a term well known in the art and is used herein consistent with that understanding. The term unsintered is used herein to describe PTFE polymer that has not been subjected to the sintering process. Unsintered PTFE may be substantially unexpanded and typically contains no substantially defined internodal distance, which may substantially reduce its porosity relative to expanded PTFE. The limited porosity of the<!-- EPO <DP n="9"> --> unsintered, substantially unexpanded PTFE may substantially reduce tissue adhesion to the unexpanded PTFE and/or migration of tissue into the unexpanded PTFE. However, the limited porosity may allow for the passage of ions and other small molecules necessary for cellular nourishment and waste transport. In some implementations, a density of one or more layers 14, 16 (<figref idrefs="f0003">FIG. 3</figref> and <figref idrefs="f0004">FIG. 4</figref>) of membrane 10 may be about 1.2 gm/cc to about 2.3 gm/cc. In some implementations, the density of one or more layers 14, 16 of membrane 10 may be about 1.45 gm/cc to about 1.55 gm/cc.</p><p id="p0023" num="0023"><figref idrefs="f0003">FIG. 3</figref> illustrates first layer 14 and <figref idrefs="f0004">FIG. 4</figref> illustrates second layer 16. First layer 14 may be configured to contact bone. (This is not intended to be limiting. In some situations a user may place the first layer of the membrane in contact with soft and/or other non-bone tissue. For example, surgeons may choose to place the expanded PTFE layer or the dense PTFE layer towards bone, or soft tissue). First layer 14 may include pores 15 configured to promote ingrowth of bone regenerating cells into first layer 14. Second layer 16 may be fixedly coupled to first layer 14 and/or be coupled to first layer 14 in other ways. Second layer 16 may be configured to substantially prevent fibrous connective tissue from growing into the bone defect. Second layer 16 may comprise a dense structure that prevents tissue ingrowth. Second layer 16 may be relatively denser than first layer 14, for example. First layer 14 and second layer 16 may be separate layers of membrane 10 (as described above), and/or first layer 14 and second layer 16 may be two surfaces on opposite sides of membrane 10 (e.g., opposite sides of a single layer).</p><p id="p0024" num="0024">By way of a non-limiting example, first layer 14 may be and/or include expanded PTFE (e-PTFE). Second layer 16 may be and/or include unsintered high density PTFE (d-PTFE) having a density of about 1.2 gm/cc to about 2.3 gm/cc. In some implementations, the density of d-PTFE may be in a range from about 1.45 grams/cc to about 1.55 grams/cc. The d-PTFE material may be unsintered and unexpanded with a nominal pore channel 13 size of less than about 5 micrometers. In some implementations, the unsintered, unexpanded d-PTFE may have a nominal pore channel 13 size of less than about 2 micrometers. In some implementations, the unsintered, unexpanded d-PTFE may have a nominal pore channel 13 size of less than about 0.5 micrometers. In some implementations, the unsintered, unexpanded d-PTFE may have a nominal pore channel 13 size of less than about 0.2 micrometers. This small pore channel size may allow a composite multi-layer material employing d-PTFE to exhibit superior functional characteristics, resulting clinically in reduced host response (inflammation), soft tissue ingrowth,<!-- EPO <DP n="10"> --> and resultant adhesions. (These pore channel 13 sizes may be smaller than pore 15 sizes in first layer 14 made from e-PTFE that promote bone ingrowth.)</p><p id="p0025" num="0025"><figref idrefs="f0005">FIG. 5</figref> illustrates a texture pattern 50 that may be formed in second layer 16 of membrane 10. The texture pattern may be formed by a plurality of indentations 52 formed in second layer 16 of membrane 10. Indentations 52 may have any shape that allows membrane 10 to function as described herein. The example shown in <figref idrefs="f0005">FIG. 5</figref> is hexagonal in shape, although other shapes are contemplated and fall within the scope of this disclosure. The indentations may have a depth less than the thickness of second layer 16. In some implementations, indentations 52 may be up to about 0.15 mm deep and up to about 0.5mm wide, for example. Indentations 52 may be dimensioned based on the intended use for membrane 10 and/or other factors. The distribution of indentations 52 may be substantially uniform over second layer 16, may vary systematically across second layer 16, may be randomly distributed across second layer 16, and/or have other distributions. For example, up to about 150 indentations may be provided per square centimeter over second layer 16. As another example, up to about 250 indentations may be provided per square centimeter over second layer 16.</p><p id="p0026" num="0026">Texture pattern 50 of second layer 16 may be made by forming a thin sheet of PTFE and then embossing the sheet with indentations. PTFE resin may be mixed with a lubricant (e.g., mineral spirits) to form a paste. The paste may be calendered between rollers to form a thin flat sheet of the desired thickness (e.g., in the range of about 0.125 mm to about 0.25 mm.) The calendering may be performed to reduce the thickness of the sheet and to impart substantially uniform strength in all directions to the sheet. The lubricant may be removed by drying the sheet at a temperature somewhat above the boiling point of the mineral spirit lubricant, but well below the sintering temperature of PTFE. After the sheet has been dried, the sheet may be embossed to form the indentations in one of its surfaces. In some implementations, the embossing step may be performed by placing a sheet of patterned polymer mesh on top of the sheet of PTFE. The patterned polymer mesh may be harder and have more compressive strength than the PTFE material. In some implementations, the polymer mesh may be a suitable commercially available fine pore-size mesh material. The polymer mesh and the PTFE sheet may be passed together between a pair of rollers, which emboss the pattern of the polymer mesh into one surface of the PTFE sheet. After embossing, the polymer sheet may be discarded. One of many possible advantages of the textured surface is to increase the surface area available for cell attachment.<!-- EPO <DP n="11"> --></p><p id="p0027" num="0027">Returning to <figref idrefs="f0001">FIG. 1</figref>, perforations 18 may comprise co-axial through-holes having common dimensions through first layer 14 and second layer 16. (In some implementations, as described herein, perforations may only be located in the second layer, with the first layer being continuous, and fabricated of lightweight polymer mesh, collagen or expanded PTFE, for example.) Perforations 18 may be configured to enhance ossification. In some implementations, perforations 18 may have a substantially circular shape. In some implementations, perforations 18 may have a substantially circular cross section. In some implementations, perforations 18 may have a form factor other than circular. For example, perforations may be substantially shaped as a square, a rectangle, a triangle, a diamond, an oval, a pentagon, a hexagon, an octagon, a free form shape, and/or other shapes. In some implementations, one or more perforations 18 may be and/or include perforations with a substantially circular cross section having a diameter of about 0.1mm or larger. In some implementations, one or more perforations 18 may be and/or include perforations with a substantially circular cross section having a diameter of about 0.5mm to about 1.0mm. In some implementations, one or more perforations 18 may be and/or include perforations with a substantially circular cross section having a diameter of up to about 3.0mm. In some implementations, the shape and/or size of perforations 18 may vary across membrane 10. For example, perforations 18 may be smaller near reinforcement binder 12 and larger near the edges of membrane 10.</p><p id="p0028" num="0028">The shapes and/or dimensions of the perforations described above are not intended to be limiting. Perforations 18 may have any size and/or shape that allows them to function as described herein. In some implementations, a size, a shape, a density, a spacing, and/or other characteristics of perforations 18 may be determined based on one or more of a material that forms membrane 10, a thickness of membrane 10, a size (e.g., length and width) of membrane 10, a shape and/or size of reinforcement binder 12, an intended use for the membrane, and/or other factors.</p><p id="p0029" num="0029">In some implementations, membrane 10 may be configured such that perforations 18 may be formed at manufacture, formed by a user (e.g., a surgeon, a doctor, a nurse, and/or other clinicians), and/or formed at other times. In some implementations, perforations 18 may be formed during an individual procedure according to the needs of the patient and/or the bone defect. For example, a user may use a sharp tool to perforate membrane 10, a tool associated with membrane 10, and or other devices to make perforations 18. In such implementations, the number and/or the spacing of the perforations<!-- EPO <DP n="12"> --> may be determined by the user. In such implementations, the shape of perforations 18 may depend on the tool used to make the perforations.</p><p id="p0030" num="0030">In some implementations, one or more secondary perforations 20 may be formed in membrane 10. Secondary perforations 20 may be configured to receive fasteners configured to hold membrane 10 in place at the bone defect. Secondary perforations 20 may have a different size, shape, and/or density relative to perforations 18. The fasteners may be pins (e.g., Titanium Master Pins manufactured by the Meisinger corporation), titanium tacks (e.g., manufactured by Salvin), screws (e.g., manufactured by Pro-Fix, Osteogenics, etc.), and/or other fastening devices.</p><p id="p0031" num="0031">Reinforcement binder 12 may comprise multiple elongated members 30 extending from a junction 32. In some implementations reinforcement binder 12 may be formed between first layer 14 and second layer 16 of membrane 10. In some implementations, reinforcement binder 12 may be formed from titanium, stainless steel, platinum, ceramics, composites, carbon fiber materials, customized micro and/or nano material based materials, coated (e.g., with a non-toxic coating) materials, and/or other materials. Reinforcement binder 12 may be bendable and may include elongate members 30 such that reinforcement binder 12 may be formed in a desired shape (e.g. at manufacture), and/or may be bent, deformed, and/or reformed by a user to obtain the desired shape prior to placement about the bone defect such that the formed shape is maintained upon placement. For example, one or more portions and/or all of reinforcement binder 12 may be bent, twisted, and/or stretched as necessary to obtain the desired shape. In some implementations, reinforcement binder 12 may be malleable and/or flexible because it is relatively thin. For example, a thin piece of titanium may be easily bent by a user.</p><p id="p0032" num="0032">As shown in <figref idrefs="f0006">FIG. 6</figref> and <figref idrefs="f0007">FIG. 7</figref>, elongated members 30 may include a first elongated member 31, for example, having a free end 33 that extends away from junction 32 with a predrilled hole 34 formed therein. In some implementations, one or more elongated members 30 may include predrilled holes 34. The pre-drilled holes may be suitable for securing a fastener such as a surgical pin or screw to the bone defect site. Reinforcement binder 12 may be placed over a bone cavity, such as an alveolar cavity, for example. <figref idrefs="f0006">FIG. 6</figref> illustrates an example of reinforcement binder 12 which has an elongate member 71, for placement over a cavity toward a lingual side of the cavity. <figref idrefs="f0006">FIG. 6</figref> illustrates two elongate members 72 and 73 in a "Y- shaped configuration" at an opposite end of reinforcement binder 12, both having holes 34 for securing a fastener. The fastener may be a surgical<!-- EPO <DP n="13"> --> screw, for example, configured to fasten membrane 10 to an area of bone, typically at a surgical site, for example on the buccal side of the jaw, or upper alveolar arch, in the repair of alveolar defects and/or maxillofacial defects, for example.</p><p id="p0033" num="0033">Layers 14 and 16 (<figref idrefs="f0003">FIG. 3</figref> and <figref idrefs="f0004">4</figref>) may be coupled with reinforcement binder 12. Coupling may include fixing, attaching, and/or otherwise joining the layers and reinforcement binder 12 together. Layers 14, 16 and reinforcement binder 12 may be coupled using any suitable means, including use of an adhesive layer for attachment and/or bonding the layers 14, 16 and reinforcement binder 12. Layers 14, 16 may partially cover reinforcement binder 12. Layers 14, 16 may substantially envelope reinforcement binder 12.</p><p id="p0034" num="0034">Dimensions of reinforcement binder 12 may be selected based on the application (e.g., based on the bone defect to be treated). Similarly, the physical and mechanical properties of reinforcement binder 12 may be selected according to application. Titanium is used as the primary example herein. Surgical grade titanium may be used to provide malleability, strength, and low weight. It should be appreciated that titanium possesses strength and weight characteristics that, together with the biologically inert nature of the metal, offers advantages in many applications. It is contemplated that some applications may dictate that other dimensions, ratios of dimensions, and/or materials may be employed. For example, repair of bone material in a pelvis and/or a hip may require the use of steel and/or other materials.</p><p id="p0035" num="0035">The structural configuration of reinforcement binder 12 may be selected to facilitate ease of placement and/or use in reconstructive repair of bone defects of various sizes, related soft tissue repair, and/or skeletal surgery, for example. The structural configuration of reinforcement binder 12 may be selected to provide one or more appendages and/or elongate members suitable for placement about bone and/or surrounding tissue. The overall shape of reinforcement binder 12 may be selected to achieve a desired strength, load distribution, membrane support, placement of fasteners, comfort, ease of insertion and/or removal, and/or achieve other effects.</p><p id="p0036" num="0036">Membrane 10 and reinforcement binder 12 may be implemented at the bone defect. Implementing membrane 10 and reinforcement binder 12 at the bone defect may comprise placing membrane 10 and reinforcement binder 12 over the bone defect, receiving a fastener with the predrilled hole that passes through at least one of first layer 14 or second layer 16 of membrane 10, coupling membrane 10 and reinforcement binder 12 with<!-- EPO <DP n="14"> --> surrounding bone, holding membrane 10 in place at the bone defect via the fastener, and/or other operations. In some implementations, reinforcement binder 12 may receive a shape imparted to reinforcement binder 12 via bending by a user (e.g., a surgeon). Membrane 10 may be placed over and/or about a bone defect (e.g., a bone cavity) and/or a target surgical site with the unsintered, textured d-PTFE (second layer 16) facing soft tissue (e.g., gingival tissue) and the expanded e-PTFE (first layer 14) facing and/or adjacent to the bone and/or skeletal cavity. This is not intended to be limiting. In some implementations, if a surgeon (for example) desires, and/or if the clinical situation dictates, the aforementioned orientation may be reversed such that second layer 16 faces bone and first layer 14 faces soft tissue.</p><p id="p0037" num="0037">For example, <figref idrefs="f0008 f0009 f0010">FIG. 8 - 10</figref> show examples of implementing membrane 10 at a bone defect. <figref idrefs="f0008">FIG. 8</figref> is a lateral cross-sectional view of an adult human maxilla after a tooth extraction showing alveolar bone 17. Soft tissue gingiva 19 covers bone 17. A tooth socket 21 provides an example of a bone defect. Normal healing of a defect may include migration of cells such as fibroblasts and gingival epithelial cells, for example. As the cells proliferate into defect 21, they may inhibit bone cell regeneration, which may result in overall loss of bone mass. In the case of extractions, the loss of bone mass may result in a loss of the alveolar ridge profile.</p><p id="p0038" num="0038"><figref idrefs="f0009">FIG. 9</figref> shows socket 21 packed with bone and covered with membrane 10. Socket 21 may be packed with granular particles of allograft, xenograft and/or bioresorbable hydroxyapatite, for example, as a precursor to bone, and/or other materials. Other materials and/or articles, such as endosseous type dental implants, may be placed into socket 21. The packed socket 21 may be covered with membrane 10. First layer 14 may be placed over and/or facing socket 21 and/or bone 17. Second layer 16 may face and/or contact tissue 19 growing over and/or around membrane 10. After membrane 10 is placed over socket 21 and bone 17, membrane 10 (e.g., reinforcement binder 12) may be secured in place via fasteners (not shown). Gingival flaps 19 may be sutured 27 over membrane 10. Membrane 10 may hold the hydroxyapatite particles and/or other materials in place in socket 21 during healing and prevent migration of cells and/or connective tissue into socket 21. However, connective tissue (e.g., gingival tissue 19) may form a weak attachment with the textured surface of second layer 16, without growing through membrane 10. The attachment may be weak enough that membrane 10 may be removed after healing without significant trauma but may be strong enough to prevent dehiscence.<!-- EPO <DP n="15"> --></p><p id="p0039" num="0039"><figref idrefs="f0010">FIG. 10</figref> shows a typical tooth extraction site after healing, but prior to removal of membrane 10. As shown in <figref idrefs="f0010">FIG. 10</figref>, the alveolar ridge profile 25 may be preserved and the gingival tissue 19 may be completely healed over ridge 25. Membrane 10 may be removed by making a small incision (not shown) in gingival tissue 19 to expose a portion of layer 23. The layer 23 may then be pulled out with forceps or the like. The material may typically be easily pulled out without trauma to the patient because the attachment of the connective tissue to the textured surface is weak.</p><p id="p0040" num="0040"><figref idrefs="f0011">FIG. 11</figref> illustrates a method 1100 for guiding bone and tissue regeneration for a bone defect with a membrane. In some implementations, the membrane may be formed from collagen, polytetrafluoroethylene, and/or other materials. The operations of method 1100 presented below are intended to be illustrative. In some implementations, method 1100 may be accomplished with one or more additional operations not described, and/or without one or more of the operations discussed. Additionally, the order in which the operations of method 1100 are illustrated in <figref idrefs="f0011">FIG. 11</figref> and described herein is not intended to be limiting.</p><p id="p0041" num="0041">At an operation 1102, a first layer of the membrane configured to contact bone may be formed. The first layer may include pores configured to promote ingrowth of bone regenerating cells into the first layer. In some implementations, operation 1102 may be performed by a layer the same as or similar to first layer 14 (shown in <figref idrefs="f0003">FIG. 3</figref> and described herein).</p><p id="p0042" num="0042">At an operation 1104, a second layer of the membrane configured to substantially prevent fibrous connective tissue from growing into the bone defect may be formed. In some implementations, the second layer may be relatively denser than the first layer. The second layer may comprise a densely woven structure, depending on the material used to make the second layer, for example. In some implementations, operation 1104 may be performed by a layer the same as or similar to second layer 16 (shown in <figref idrefs="f0004">FIG. 4</figref> and described herein).</p><p id="p0043" num="0043">At an operation 1106 the second layer may be fixedly coupled to the first layer. In some implementations, operation 1106 may be performed by layers the same as or similar to second layer 16 (shown in <figref idrefs="f0004">FIG. 4</figref> and described herein) and first layer 14 (shown in <figref idrefs="f0003">FIG. 3</figref> and described herein).<!-- EPO <DP n="16"> --></p><p id="p0044" num="0044">At an operation 1108, one or more perforations through the membrane may be formed. The perforations may comprise co-axial through-holes having common dimensions through the first layer and the second layer. The perforations may be configured to enhance ossification. In some implementations, forming the one or more perforations may include forming the perforations with a substantially circular cross section having a diameter of about 0.1 mm or larger. In some implementations, forming the one or more perforations may include forming the perforations with a substantially circular cross section having a diameter of about 0.5mm to about 1.0mm. In some implementations, operation 1108 may comprise determining one or more of a size, a density, a spacing, and/or other characteristics of the perforations based on one or more of a material that forms the membrane, a thickness of the membrane, a size of the membrane, and/or other factors. In some implementations, operation 1108 may comprise forming one or more secondary perforations configured to receive fasteners configured to hold the membrane in place at the bone defect. The fasteners may be pins, for example, and/or other fastening devices. In some implementations, operation 1108 may be performed by perforations the same as or similar to perforations 18 (shown in <figref idrefs="f0001">FIG. 1</figref> and described herein).</p><p id="p0045" num="0045">At an operation 1110, a reinforcement binder may be formed. The reinforcement binder may comprise multiple elongated members extending from a junction. The elongated members may include a first elongated member, for example, having a free end that extends away from the junction with a predrilled hole formed therein. In some implementations, operation 1110 may be performed by a reinforcement binder the same as or similar to reinforcement binder 12 (shown in <figref idrefs="f0001">FIG. 1</figref> and described herein).</p><p id="p0046" num="0046">At an operation 1112, the membrane and the reinforcement binder may be implemented at the bone defect. Implementing the membrane and the reinforcement binder at the bone defect may comprise placing the membrane and the reinforcement binder over the bone defect, receiving a fastener with the predrilled hole that passes through at least one of the first or second layer of the membrane, and coupling the membrane and the reinforcement binder with surrounding bone and holding the membrane in place at the bone defect via the fastener. In some implementations the reinforcement binder may be formed between the first layer and the second layer of the membrane. In some implementations, the reinforcement binder may be formed from titanium and may receive a shape imparted to the reinforcement binder via bending by a user. In some implementations, operation 1112 may be performed by a membrane the same as or similar to membrane 10 (shown in <figref idrefs="f0001">FIG. 1</figref><!-- EPO <DP n="17"> --> and described herein) and a reinforcement binder the same as or similar to reinforcement binder 12 (shown in <figref idrefs="f0001">FIG. 1</figref> and described herein.</p><p id="p0047" num="0047">As described above and illustrated in <figref idrefs="f0012">FIG. 12</figref>, in some implementations, membrane 10 may be configured such that first layer 14 is a thin layer of expanded PTFE (and/or other lightweight mesh polymer material and/or collagen) having pores in a size range of about 30 microns to about 1000 microns, but no perforations. In these implementations, first layer 14 is not perforated, but rather covers second layer 16 of dense PTFE, which is perforated (e.g., perforations 18). These implementations may create a (e.g., laminated) two-layer membrane, with one layer (e.g., first layer 14) comprising an open-structured mesh and the second layer (e.g., second layer 16) comprising a high density, cell occlusive material. Such implementations may still allow communication of large molecules between the periosteum and the underlying bone graft, just as when perforations 18 are through both layers of membrane 10. As shown in <figref idrefs="f0012">FIG. 12</figref>, such implementations, may include a reinforcement binder 12 (e.g., a flexible titanium reinforcement binder) as described herein.</p><p id="p0048" num="0048"><figref idrefs="f0013">FIG. 13</figref> illustrates treatment of a discontinuity defect with membrane 10. <figref idrefs="f0013">FIG. 13</figref> illustrates a bone 1300 and a defect 1302. Membrane 10 may include perforations 18, reinforcement binder 12, and/or other components. Membrane 10 may be placed across, over, and/or around defect 1302 and fastened in place at defect 1302 by screws, tacks, pins, and/or other fasteners 1304. Membrane 10 may facilitate bone regeneration 1306 as described herein.</p><p id="p0049" num="0049"><figref idrefs="f0014">FIG. 14</figref> illustrates treatment of a vertical defect with membrane 10. <figref idrefs="f0014">FIG. 14</figref> illustrates a bone 1400 and a defect 1402. Membrane 10 may include perforations 18, reinforcement binder 12, and/or other components. Membrane 10 may be placed across, over, and/or around defect 1402 and fastened in place at defect 1402 by screws, tacks, pins, and/or other fasteners 1404. Membrane 10 may facilitate bone regeneration 1406 as described herein.</p><p id="p0050" num="0050"><figref idrefs="f0015">FIG. 15</figref> illustrates treatment of a horizontal defect with membrane 10. <figref idrefs="f0015">FIG. 15</figref> illustrates a bone 1500 and a defect 1502. Membrane 10 may include perforations 18, reinforcement binder 12, and/or other components. Membrane 10 may be placed across, over, and/or around defect 1502 and fastened in place at defect 1502 by screws, tacks, pins, and/or other fasteners 1504. Membrane 10 may facilitate bone regeneration 1506 as described herein.<!-- EPO <DP n="18"> --></p><p id="p0051" num="0051">Although the system(s) and/or method(s) of this disclosure have been described in detail for the purpose of illustration based on what is currently considered to be the most practical and preferred implementations, it is to be understood that such detail is solely for that purpose and that the disclosure is not limited to the disclosed implementations, but, on the contrary, is intended to cover modifications and equivalent arrangements that are within the spirit and scope of the appended claims. For example, it is to be understood that the present disclosure contemplates that, to the extent possible, one or more features of any implementation can be combined with one or more features of any other implementation.</p></description><claims mxw-id="PCLM90460580" lang="EN" load-source="patent-office"><!-- EPO <DP n="19"> --><claim id="c-en-0001" num="0001"><claim-text>A membrane configured to guide bone and tissue regeneration for a bone defect, the membrane comprising:
<claim-text>a first layer configured to contact bone, the first layer including pores configured to promote ingrowth of bone regenerating cells into the first layer;</claim-text>
<claim-text>a second layer configured to substantially prevent fibrous connective tissue from growing into the bone defect, the second layer comprising a dense structure, the second layer fixedly coupled to the first layer; and</claim-text>
<claim-text>one or more perforations through the membrane, the perforations comprising co-axial through-holes having common dimensions through the first layer and the second layer, the perforations configured to enhance ossification.</claim-text></claim-text></claim><claim id="c-en-0002" num="0002"><claim-text>The membrane of claim 1, wherein the perforations are substantially circular and have a diameter of about 0.1 mm or larger.</claim-text></claim><claim id="c-en-0003" num="0003"><claim-text>The membrane of claim 1, wherein the perforations are substantially circular and have a diameter of about 0.5mm to about 1.0mm.</claim-text></claim><claim id="c-en-0004" num="0004"><claim-text>The membrane of claim 1, wherein the membrane is formed from one or more of collagen, polytetrafluoroethylene, bioresorbable polymer, animal tissue, human tissue, or a combination thereof.</claim-text></claim><claim id="c-en-0005" num="0005"><claim-text>The membrane of claim 1, wherein one or more of a size, a density, or a spacing of the perforations is determined based on one or more of a material that forms the membrane, a thickness of the membrane, or a size of the membrane.</claim-text></claim><claim id="c-en-0006" num="0006"><claim-text>The membrane of claim 1, further comprising one or more secondary perforations configured to receive fasteners configured to hold the membrane in place at the bone defect.</claim-text></claim><claim id="c-en-0007" num="0007"><claim-text>The membrane of claim 6, wherein the fasteners include one or more of pins, tacks, sutures, or screws.</claim-text></claim><claim id="c-en-0008" num="0008"><claim-text>The membrane of claim 1, further comprising a reinforcement binder configured to be placed over the bone defect and couple with surrounding bone, the reinforcement binder comprising multiple elongated members extending from a junction, the elongated members including a first elongated member having a free end that extends away from the junction with a predrilled hole formed therein, the predrilled<!-- EPO <DP n="20"> --> hole configured to receive a fastener that passes through at least one of the first or second layer of the membrane and holds the membrane in place at the bone defect.</claim-text></claim><claim id="c-en-0009" num="0009"><claim-text>The membrane of claim 8, wherein the reinforcement binder is formed between the first layer and the second layer of the membrane.</claim-text></claim><claim id="c-en-0010" num="0010"><claim-text>The membrane of claim 8, wherein the reinforcement binder is a titanium reinforcement binder and is configured to be bent into a desired shape by a user.</claim-text></claim><claim id="c-en-0011" num="0011"><claim-text>A method for guiding bone and tissue regeneration for a bone defect with a membrane, the method comprising:
<claim-text>forming a first layer of the membrane configured to contact bone, the first layer including pores configured to promote ingrowth of bone regenerating cells into the first layer;</claim-text>
<claim-text>forming a second layer of the membrane configured to substantially prevent fibrous connective tissue from growing into the bone defect, the second layer comprising a dense structure;</claim-text>
<claim-text>fixedly coupling the second layer to the first layer; and</claim-text>
<claim-text>forming one or more perforations through the membrane, the perforations comprising co-axial through-holes having common dimensions through the first layer and the second layer, the perforations configured to enhance ossification.</claim-text></claim-text></claim><claim id="c-en-0012" num="0012"><claim-text>The method of claim 11, wherein forming the one or more perforations includes forming the perforations with a substantially circular cross section having a diameter of about 0.1mm or larger.</claim-text></claim><claim id="c-en-0013" num="0013"><claim-text>The method of claim 11, wherein forming the one or more perforations includes forming the perforations with a substantially circular cross section having a diameter of about 0.5mm to about 1.0mm.</claim-text></claim><claim id="c-en-0014" num="0014"><claim-text>The method of claim 11, further comprising forming the membrane from one or more of collagen, polytetrafluoroethylene, bioresorbable polymer, animal tissue, human tissue, or combination thereof.</claim-text></claim><claim id="c-en-0015" num="0015"><claim-text>The method of claim 11, further comprising determining one or more of a size, a density, or a spacing of the perforations based on one or more of a material that forms the membrane, a thickness of the membrane, or a size of the membrane.<!-- EPO <DP n="21"> --></claim-text></claim><claim id="c-en-0016" num="0016"><claim-text>The method of claim 11, further comprising forming one or more secondary perforations configured to receive fasteners configured to hold the membrane in place at the bone defect.</claim-text></claim><claim id="c-en-0017" num="0017"><claim-text>The method of claim 16, wherein the fasteners include one or more of pins, tacks, sutures, or screws.</claim-text></claim><claim id="c-en-0018" num="0018"><claim-text>The method of claim 11, further comprising forming a reinforcement binder, the reinforcement binder comprising multiple elongated members extending from a junction, the elongated members including a first elongated member having a free end that extends away from the junction with a predrilled hole formed therein;<br/>
placing the membrane and the reinforcement binder over the bone defect; receiving a fastener with the predrilled hole that passes through at least one of the first or second layer of the membrane; and<br/>
coupling the membrane and the reinforcement binder with surrounding bone and holding the membrane in place at the bone defect via the fastener.</claim-text></claim><claim id="c-en-0019" num="0019"><claim-text>The method of claim 18, further comprising forming the reinforcement binder between the first layer and the second layer of the membrane.</claim-text></claim><claim id="c-en-0020" num="0020"><claim-text>The method of claim 18, wherein the reinforcement binder is formed from titanium, the method further comprising receiving a shape imparted to the reinforcement binder via bending by a user.</claim-text></claim><claim id="c-en-0021" num="0021"><claim-text>A membrane configured to guide bone and tissue regeneration for a bone defect, the membrane comprising:
<claim-text>a first layer configured to contact bone, the first layer including pores configured to promote ingrowth of bone regenerating cells into the first layer;</claim-text>
<claim-text>a second layer configured to substantially prevent fibrous connective tissue from growing into the bone defect, the second layer comprising a dense structure, the second layer bonded to the first layer; and</claim-text>
<claim-text>one or more perforations through the second layer of the membrane, the perforations comprising through-holes through the second layer configured to enhance ossification.</claim-text><!-- EPO <DP n="22"> --></claim-text></claim><claim id="c-en-0022" num="0022"><claim-text>The membrane of claim 21, wherein the first layer comprises a substantially continuous sheet of one or more of a lightweight porous polymer mesh, a lightweight porous bioresorbable polymer mesh, collagen, or expanded polytetrafluoroethylene.</claim-text></claim><claim id="c-en-0023" num="0023"><claim-text>A method for guiding bone and tissue regeneration for a bone defect with a membrane, the method comprising:
<claim-text>forming a first layer of the membrane configured to contact bone, the first layer including pores configured to promote ingrowth of bone regenerating cells into the first layer;</claim-text>
<claim-text>forming a second layer of the membrane configured to substantially prevent fibrous connective tissue from growing into the bone defect, the second layer comprising a dense structure;</claim-text>
<claim-text>bonding the second layer to the first layer; and</claim-text>
<claim-text>forming one or more perforations through the second layer, the perforations comprising through-holes through the second layer, the perforations configured to enhance ossification.</claim-text></claim-text></claim><claim id="c-en-0024" num="0024"><claim-text>The method of claim 23, wherein the first layer comprises a substantially continuous sheet of one or more of a lightweight porous polymer mesh, a lightweight porous bioresorbable polymer mesh, collagen, or expanded polytetrafluoroethylene.</claim-text></claim></claims><drawings mxw-id="PDW20423198" load-source="patent-office"><!-- EPO <DP n="23"> --><figure id="f0001" num="1"><img id="if0001" file="imgf0001.tif" wi="165" he="209" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="24"> --><figure id="f0002" num="2"><img id="if0002" file="imgf0002.tif" wi="165" he="209" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="25"> --><figure id="f0003" num="3"><img id="if0003" file="imgf0003.tif" wi="98" he="167" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="26"> --><figure id="f0004" num="4"><img id="if0004" file="imgf0004.tif" wi="98" he="167" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="27"> --><figure id="f0005" num="5"><img id="if0005" file="imgf0005.tif" wi="156" he="204" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="28"> --><figure id="f0006" num="6"><img id="if0006" file="imgf0006.tif" wi="81" he="183" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="29"> --><figure id="f0007" num="7"><img id="if0007" file="imgf0007.tif" wi="109" he="187" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="30"> --><figure id="f0008" num="8"><img id="if0008" file="imgf0008.tif" wi="95" he="169" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="31"> --><figure id="f0009" num="9"><img id="if0009" file="imgf0009.tif" wi="95" he="169" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="32"> --><figure id="f0010" num="10"><img id="if0010" file="imgf0010.tif" wi="95" he="169" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="33"> --><figure id="f0011" num="11"><img id="if0011" file="imgf0011.tif" wi="141" he="210" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="34"> --><figure id="f0012" num="12"><img id="if0012" file="imgf0012.tif" wi="152" he="199" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="35"> --><figure id="f0013" num="13"><img id="if0013" file="imgf0013.tif" wi="131" he="199" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="36"> --><figure id="f0014" num="14"><img id="if0014" file="imgf0014.tif" wi="146" he="211" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="37"> --><figure id="f0015" num="15"><img id="if0015" file="imgf0015.tif" wi="146" he="204" img-content="drawing" img-format="tif"/></figure></drawings><search-report-data><doc-page id="srep0001" file="srep0001.tif" wi="158" he="233" type="tif"/><doc-page id="srep0002" file="srep0002.tif" wi="158" he="233" type="tif"/></search-report-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
